ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10051	Companies
205085	Keywords
135325	Articles
108731	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 09/29/2025 at 22:05, 5 months 19 days ago

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces acceptance of additional late-breaking abstract from the ABTECT Phase 3 induction trials to be presented at 2025 United European Gastroenterology (UEG) Meeting

Abivax Ulcerative Colitis Gastroenterology Late-breaking Abstract ABTECT Phase 3
BRIEF

published on 09/23/2025 at 22:10, 5 months 25 days ago

Abivax: Presentation of promising data on obefazimod at the 2025 UEG congress

Abivax Obefazimod Ulcerative Colitis Phase 3 UEG Congress
PRESS RELEASE

published on 09/23/2025 at 22:05, 5 months 25 days ago

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces presentation of late-breaking abstract for Obefazimod at 2025 United European Gastroenterology Meeting, showcasing potential as a new therapy for ulcerative colitis

Abivax Obefazimod Ulcerative Colitis Late-breaking Abstract UEG Meeting
BRIEF

published on 09/16/2025 at 18:05, 6 months 2 days ago

ABIVAX: Distribution of Share Capital and Voting Rights

Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF

published on 09/16/2025 at 10:04, 6 months 2 days ago

JP Morgan Chase exceeds 5% threshold in ABIVAX

Capital Actions Abivax Threshold Crossing JP Morgan Chase
BRIEF

published on 09/12/2025 at 17:50, 6 months 6 days ago

Abivax Joins CAC Mid 60 and SBF 120 Indices

Euronext Paris Biotechnology Abivax SBF 120 CAC Mid 60
PRESS RELEASE

published on 09/12/2025 at 17:45, 6 months 6 days ago

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
Abivax to join CAC Mid 60 and SBF 120 Indices on Euronext Paris following annual review, enhancing visibility and investor base

Euronext Paris Abivax SBF 120 Index Inclusion CAC Mid 60
BRIEF

published on 09/08/2025 at 22:05, 6 months 10 days ago

Abivax Reports First Half 2025 Financial Performance

Financial Results Research And Development Convertible Notes Public Offering Cash Reserves
PRESS RELEASE

published on 09/08/2025 at 22:00, 6 months 10 days ago

Abivax Presents First Half 2025 Financial Results
Abivax presents first half 2025 financial results, revealing operating loss increase and net loss for the period, also updates on clinical programs and public offering

Financial Results Abivax Public Offering Clinical Programs Operating Loss
BRIEF

published on 09/02/2025 at 11:00, 6 months 16 days ago

JP Morgan Chase & Co. Crosses Threshold at ABIVAX

Voting Rights Capital Abivax Threshold Crossing JP Morgan

Accesswire

Published on 03/19/2026 at 01:05, 4 hours 18 minutes ago

Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 5 hours 38 minutes ago

Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 8 hours 23 minutes ago

PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/18/2026 at 19:05, 10 hours 18 minutes ago

Deposit Modeling at Thor Shows that the Proven Thor Epithermal Deposit is Flanked on Both Sides by a Much Larger Deposit
Published on 03/18/2026 at 18:10, 11 hours 13 minutes ago

Silver X Mining Closes C$69M Brokered Private Placement of Secured Convertible Debentures

View all ACCESSWIRE

EQS Group

Published on 03/19/2026 at 03:50, 1 hour 33 minutes ago

AWE2026 Signals the Future: A Defining Moment for the Age of AI
Published on 03/18/2026 at 22:00, 7 hours 23 minutes ago

aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term
Published on 03/18/2026 at 18:53, 10 hours 30 minutes ago

EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
Published on 03/18/2026 at 18:37, 10 hours 46 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/18/2026 at 18:27, 10 hours 56 minutes ago

POS-Transaction in Own Shares

Les Echos

Published on 03/18/2026 at 19:41, 9 hours 41 minutes ago

Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 11 hours 23 minutes ago

Deezer achieves profitability in FY25 as strategy delivers tangible results
Published on 03/18/2026 at 17:45, 11 hours 38 minutes ago

Infotel : 2025 full-year results. Launch of a new Infotel 2030 strategic plan. Revenue target of €500 million by 2030.
Published on 03/18/2026 at 17:40, 11 hours 43 minutes ago

260318 BENETEAU Presentation FY 2025
Published on 03/18/2026 at 17:40, 11 hours 43 minutes ago

260318 BENETEAU FY 2025 Results

View all LES ECHOS COMFI WIRE